Dr. Chambers is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4069 Lake Dr SE
Ste 312
Grand Rapids, MI 49546Phone+1 616-267-8700Fax+1 616-267-8247
Summary
- Dr. Christopher Chambers is a vascular surgeon in Grand Rapids, MI and is affiliated with Corewell Health. He received his medical degree from University of South Florida College of Medicine, trained at Washington University in St. Louis, and has been in practice 16 years. He is experienced in peripheral vascular disease, carotid disease, aortic surgery, endovascular surgery, and aortic disease.
Education & Training
Washington University/B-JH/SLCH ConsortiumResidency, Surgery, 2002 - 2007
University of South Florida College of MedicineClass of 2002
Certifications & Licensure
MI State Medical License 2007 - 2027
IL State Medical License 2021 - 2026- American Board of Surgery Surgery
- American Board of Surgery Vascular Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
- Fellow American College of Surgeons
Clinical Trials
- Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI) Start of enrollment: 2010 Jun 01
- Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix® System Start of enrollment: 2013 Dec 01
Publications & Presentations
PubMed
- 20 citationsTreatment of nonaortic aneurysms in the endograft era: aneurysms of the innominate and subclavian arteries.Christopher M. Chambers, John A. Curci
Seminars in Vascular Surgery. 2005-12-01 - 68 citationsEffects of l-Triiodothyronine and the Thyromimetic L-94901 on Serum Lipoprotein Levels and Hepatic Low-Density Lipoprotein Receptor, 3-Hydroxy-3-methylglutaryl Coenzym...Gene C. Ness, Dayami Lopez, Christopher M. Chambers, William P. Newsome, Peter Cornelius
Biochemical Pharmacology. 1998-07-01 - 35 citationsComplication Rates for Percutaneous Lower Extremity Arterial Antegrade AccessBrian J. Wheatley, M. Ashraf Mansour, P. Michael Grossman, Khan Munir, Robert F. Cali
Archives of Surgery. 2011-04-01
Journal Articles
- Anthrax Toxin Receptor 1 Is Essential for Arteriogenesis in a Mouse Model of Hindlimb Ischemia.Andersen NJ1,2, Boguslawski EA2, Naidu AS2, Szot C3, Bromberg-White JL2, Kits K2,4, Kuk CY2, Holton LE1, St Croix B3, Chambers CM1,2, Duesbery NS2., Plos One, 1/19/2016
Press Mentions
Inovio’s Recent Data Fails to Impress Some Analysts but Overall Data Looks Promising & Study Backed by Department of DefenseDecember 29th, 2020
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
